Bain Capital Life Sciences Investors’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $194M | Hold |
|
|||||
|
2025
Q1 | $219M | Hold |
|
|||||
|
2024
Q4 | $275M | Buy |
|
|||||
|
2024
Q3 | $174M | Hold |
|
|||||
|
2024
Q2 | $201M | Hold |
|
|||||
|
2024
Q1 | $248M | Hold |
|
|||||
|
2023
Q4 | $117M | Hold |
|
|||||
|
2023
Q3 | $96.9M | Hold |
|
|||||
|
2023
Q2 | $125M | Buy |
|
|||||
|
2023
Q1 | $110M | Hold |
|
|||||
|
2022
Q4 | $90.5M | Buy |
|